Inovio Pharmaceuticals, Inc. (BMV:INO)

Inovio Pharmaceuticals Revenue

Inovio Pharmaceuticals had revenue of $182.34K USD in the twelve months ending September 30, 2025, down -10.36% year-over-year. In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K, down -73.83%.

• Revenue (ttm): $182.34K
• Revenue Growth: -10.36%
• P/S Ratio: 773.67
• Revenue / Employee: $1.36K
• Employees: 134
• Market Cap: 2.59B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	217.76K	-614.25K	-73.83%
Dec 31, 2023	832.01K	-9.43M	-91.89%
Dec 31, 2022	10.26M	8.49M	478.23%
Dec 31, 2021	1.77M	-5.64M	-76.05%
Dec 31, 2020	7.41M	3.06M	70.32%
Dec 31, 2019	4.35M	-26.30M	-85.80%
Dec 31, 2018	30.65M	-25.38M	-45.29%
Dec 31, 2017	56.03M	-8.21M	-12.78%
Dec 31, 2016	64.25M	9.98M	18.39%
Dec 31, 2015	54.27M	41.25M	316.88%
Dec 31, 2014	13.02M	-4.25M	-24.62%
Dec 31, 2013	17.27M	9.69M	127.92%
Dec 31, 2012	7.58M	-11.45M	-60.17%
Dec 31, 2011	19.02M	6.73M	54.79%
Dec 31, 2010	12.29M	-5.82M	-32.16%
Dec 31, 2009	18.11M	15.00M	481.09%
Dec 31, 2008	3.12M	-4.64M	-59.83%
Dec 31, 2007	7.76M	1.79M	29.91%
Dec 31, 2006	5.97M	-3.47M	-36.73%
Dec 31, 2005	9.44M	-	-